Home › Acute Myeloid Leukemia › Illinois › Champaign
Acute Myeloid Leukemia clinical trials in Champaign, IL
3 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Champaign (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Carle Cancer Center, Urbana · 2 mi away
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Carle Cancer Center, Urbana · 2 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Carle Cancer Center, Urbana · 2 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA30 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Champaign
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer11 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Endometrial Cancer6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Melanoma6 studies
- Colorectal Cancer6 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.